Astellas Pharma, Inc. (ALPMF)
13.25
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Astellas Pharma Total Assets (Quarterly) : 22.42B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 22.42B |
| December 31, 2025 | 22.99B |
| September 30, 2025 | 23.36B |
| June 30, 2025 | 23.09B |
| March 31, 2025 | 22.33B |
| December 31, 2024 | 21.96B |
| September 30, 2024 | 24.20B |
| June 30, 2024 | 23.22B |
| March 31, 2024 | 23.59B |
| December 31, 2023 | 23.89B |
| September 30, 2023 | 23.74B |
| June 30, 2023 | 19.36B |
| March 31, 2023 | 18.46B |
| December 31, 2022 | 19.05B |
| September 30, 2022 | 17.85B |
| June 30, 2022 | 18.27B |
| March 31, 2022 | 19.22B |
| December 31, 2021 | 20.46B |
| September 30, 2021 | 20.27B |
| June 30, 2021 | 20.27B |
| March 31, 2021 | 20.58B |
| December 31, 2020 | 22.25B |
| September 30, 2020 | 21.20B |
| June 30, 2020 | 20.91B |
| March 31, 2020 | 21.45B |
| Date | Value |
|---|---|
| December 31, 2019 | 18.31B |
| September 30, 2019 | 18.32B |
| June 30, 2019 | 17.89B |
| March 31, 2019 | 17.14B |
| December 31, 2018 | 17.58B |
| September 30, 2018 | 16.61B |
| June 30, 2018 | 16.85B |
| March 31, 2018 | 17.47B |
| December 31, 2017 | 17.17B |
| September 30, 2017 | 16.84B |
| June 30, 2017 | 16.92B |
| March 31, 2017 | 16.28B |
| December 31, 2016 | 15.90B |
| September 30, 2016 | 16.92B |
| June 30, 2016 | 16.51B |
| March 31, 2016 | 16.01B |
| December 31, 2015 | 14.86B |
| September 30, 2015 | 14.78B |
| June 30, 2015 | 14.55B |
| March 31, 2015 | 14.96B |
| December 31, 2014 | 15.45B |
| September 30, 2014 | 15.64B |
| June 30, 2014 | 15.95B |
| March 31, 2014 | |
| December 31, 2013 | 14.89B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 25.18B |
| Takeda Pharmaceutical Co., Ltd. | 97.13B |
| Eisai Co., Ltd. | 9.109B |
| Chugai Pharmaceutical Co., Ltd. | 14.24B |
| Santen Pharmaceutical Co., Ltd. | 2.659B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.91B |
| Shareholders Equity (Quarterly) | 11.51B |
| Debt to Equity Ratio | 0.3091 |
| Current Ratio | 1.167 |
| Net Debt Paydown Yield | 2.08% |